TF

Timothy J. Fultz

AP Adamas Pharmaceuticals: 27 patents #2 of 27Top 8%
GI Gen-Probe Incorporated: 7 patents #91 of 338Top 30%
AP Adamas Pharma: 6 patents #2 of 10Top 20%
CH Chiron: 4 patents #142 of 583Top 25%
📍 Monticello, GA: #2 of 26 inventorsTop 8%
🗺 Georgia: #393 of 35,610 inventorsTop 2%
Overall (All Time): #66,546 of 4,157,543Top 2%
44
Patents All Time

Issued Patents All Time

Showing 1–25 of 44 patents

Patent #TitleCo-InventorsDate
12233033 Amantadine compositions, preparations thereof, and methods of use Gregory T. Went, Sangita Ghosh, Natalie McClure 2025-02-25
11903908 Methods of administering amantadine Gregory T. Went, Natalie McClure 2024-02-20
11077073 Methods of using amantadine compositions Gregory T. Went, Sangita Ghosh, Natalie McClure 2021-08-03
11065213 Amantadine compositions and preparations thereof Gregory T. Went, Sangita Ghosh, Natalie McClure 2021-07-20
10987324 Methods and compositions for the treatment of seizure-related disorders Jack Nguyen, David Chernoff, Sangita Ghosh, Gregory T. Went 2021-04-27
10973783 Methods and compositions for the treatment of seizure-related disorders Jack Nguyen, David Chernoff, Sangita Ghosh, Gregory T. Went 2021-04-13
10646456 Methods of administering amantadine Gregory T. Went, Natalie McClure 2020-05-12
10154971 Methods of administering amantadine Gregory T. Went, Natalie McClure 2018-12-18
9072697 Composition and method for treating neurological disease Gregory T. Went 2015-07-07
8987333 Composition and method for treating neurological disease Gregory T. Went, Seth Porter, Laurence R. Meyerson, Timothy S. Burkoth 2015-03-24
8895614 Composition and method for treating neurological disease Gregory T. Went, Seth Porter, Laurence R. Meyerson, Timothy S. Burkoth 2014-11-25
8895615 Composition and method for treating neurological disease Gregory T. Went, Seth Porter, Laurence R. Meyerson, Timothy S. Burkoth 2014-11-25
8895616 Composition and method for treating neurological disease Gregory T. Went, Seth Porter, Laurence R. Meyerson, Timothy S. Burkoth 2014-11-25
8895617 Composition and method for treating neurological disease Gregory T. Went, Seth Porter, Laurence R. Meyerson, Timothy S. Burkoth 2014-11-25
8895618 Composition and method for treating neurological disease Gregory T. Went, Seth Porter, Laurence R. Meyerson, Timothy S. Burkoth 2014-11-25
8889740 Composition and method for treating neurological disease Gregory T. Went, Seth Porter, Laurence R. Meyerson, Timothy S. Burkoth 2014-11-18
8796337 Composition and method for treating neurological disease Gregory T. Went, Seth Porter, Laurence R. Meyerson, Timothy S. Burkoth 2014-08-05
8598233 Method for administering an NMDA receptor antagonist to a subject Gregory T. Went, Laurence R. Meyerson 2013-12-03
8580858 Compositions for the treatment of CNS-related conditions Gregory T. Went, Laurence R. Meyerson 2013-11-12
8426472 Method and composition for administering an NMDA receptor antagonist to a subject Gregory T. Went, Seth Porter, Laurence R. Meyerson, Timothy S. Burkoth 2013-04-23
8389578 Composition and method for treating neurological disease Gregory T. Went, Seth Porter, Laurence R. Meyerson, Timothy S. Burkoth 2013-03-05
8362085 Method for administering an NMDA receptor antagonist to a subject Gregory T. Went, Laurence R. Meyerson 2013-01-29
8338486 Methods for the treatment of CNS-related conditions Gregory T. Went, Laurence R. Meyerson 2012-12-25
8338485 Compositions for the treatment of CNS-related conditions Gregory T. Went, Laurence R. Meyerson 2012-12-25
8329752 Composition for administering an NMDA receptor antagonist to a subject Gregory T. Went, Laurence R. Meyerson 2012-12-11